Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma

Conclusion This multi-center collaborative study suggests that IOP-lowering efficacy of travoprost ophthalmic solution persists during the day at the clinically relevant level in subjects with NTG. Funding Alcon Japan Ltd. Trial registration University Hospital Medical Information Network, UMIN ID: 000011621.

http://link.springer.com/10.1007/s12325-016-0297-6

Source: Advances in Therapy - February 9, 2016 Category: Drugs & Pharmacology Source Type: research